2012
DOI: 10.4267/2042/48364
|View full text |Cite
|
Sign up to set email alerts
|

PRKCI (protein kinase C, iota)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…Bodyweights of NA 2 PD‐treated mice remained normal, while the bodyweights of control and DOX groups rapidly decreased by 18 % and 11 %, respectively (Figure 6f, and S30). Besides, we used luciferase‐expressed LLC cells to construct orthotopic NSCLC murine models and monitored the cancer development through bioluminescence [31] . NA 2 PD group mice showed minimal bioluminescent areas and intensities during the treatment (Figure 6g).…”
Section: Resultsmentioning
confidence: 99%
“…Bodyweights of NA 2 PD‐treated mice remained normal, while the bodyweights of control and DOX groups rapidly decreased by 18 % and 11 %, respectively (Figure 6f, and S30). Besides, we used luciferase‐expressed LLC cells to construct orthotopic NSCLC murine models and monitored the cancer development through bioluminescence [31] . NA 2 PD group mice showed minimal bioluminescent areas and intensities during the treatment (Figure 6g).…”
Section: Resultsmentioning
confidence: 99%